SORD: A Lesson in Repurposing Drugs to Treat Hereditary Neuropathy
March 11, 2021
Research from a mutation on the SORD gene
The latest from HNF: research updates, patient stories, advocacy wins, events, and CMT community news.
No matches for .
Showing 169 to 180 of 314
March 11, 2021
Research from a mutation on the SORD gene
March 11, 2021
Community connected with the TRPV4 HN team at Johns Hopkins
February 23, 2021
The PREMIER Trial, which is being conducted in patients with mild-to-moderate CMT1A, is expected to enroll approximately 350 subjects ages 16-65 with a confirmed genetic diagnosis of CMT1A.
January 27, 2021
Ginnell McDonald interview on writing Brace Yourself For Another Day
January 21, 2021
Meet Marc Daigle, Christine Panico, Julie Stone who offer live classes
January 20, 2021
Research with the Department of Cellular and Integrative Physiology UT Health San Antonio, TX
January 18, 2021
What GRIN is and why you should join
January 13, 2021
Kundalini yoga is a holistic yoga that incorporates repetitive physical movement and sometimes static postures timed with breath-work, chanting, meditation, and relaxation.
January 11, 2021
Hear from Rob Smith, Inventor and Director of Active Hands and learn about these life-impacting products designed especially for people living with reduced hand function.
January 11, 2021
Join us as we explore the power of Nutrition with CMT patient and Functional Medicine Coach Paul Fowler.
January 11, 2021
Join Estela & Amin as they discuss navigating online dating and relationships with CMT.
January 8, 2021
New CMT-Connect Webinar Pain Series will focus on a particular type of pain, its common causes, available treatments and future treatments on the horizon.
Changes how this site looks for you, and are saved on this device.
We use cookies to see how the site is used (analytics) and to power embedded videos and podcasts. Analytics stay off until you say yes. See our privacy policy.
Be the first to know
Research moves fast. Add your number and we will text you the things that matter most: new treatment news, trial openings, and ways to take part before they fill up.